Signs MoU with Mexican Grupo Seara and French Cardiologs to deliver best-in-class predictive diagnosis for cardiovascular diseases.
Bangalore based startup, Cardiotrack, which provides best-in-class predictive diagnosis for cardiovascular diseases, is strengthening its footprint in Mexico, France, and India as well. Cardiotrack, is a global name that uses innovative medical technology to create breakthrough diagnostic products in the cardiac space and improve people’s lives. Cardiotrack’s parent company uber Diagnostics is headquartered in Singapore.
Cardiotrack, on Tuesday, announced that it inked a Memorandum of Understanding (MoU) with Grupo Seara, one of the largest entrepreneurial healthcare services companies in Mexico. Founded by Eduardo Serna Barragan, Grupo Seara will adopt advanced patient-centric technologies from Cardiotrack to deliver high-level operational efficiency and quality diagnostics for the patients at an affordable cost.
Founded by industry veterans Ashim Roy and Avin Agrawal, the Cardiotrack platform is designed to fulfill the basic requirements of primary care. Using Cardiotrack, doctors can detect heart health problems accurately, consult specialists, refer and track patients, maintain medical history and start the intervention process. At a time when coronary heart disease is one of the major healthcare challenges facing the World, Cardiotrack is addressing the concern through its innovative diagnostic solutions for cardiac care, globally.
The MoU was signed at the TEPC event, 2017, in the presence of the senior leadership teams from both companies. A similar MoU was signed with Cardiologs, a French AI company, to deliver best-in-class predictive diagnosis for cardiovascular diseases. In fact, Cardiotrack, recognized globally for its robust hardware, will be integrated with AI software developed and deployed in France.
Cardiotrack’s collaborations will revolutionize the way cardiovascular diseases are diagnosed. The solutions will offer features that are currently only available in ECG machines priced many times higher. The AI based solution is designed for use in primary healthcare clinics (PHC) and will bring a tremendous change to affordability and accessibility of quality heart health diagnosis and intervention.
Talking about the collaborations, Ashim Roy, cofounder of Cardiotrack, said, “Since Cardiotrack’s inception in September 2015, approximately over 16,000 patient scans have been done using over 200 devices. The deployments have been in India as well as in countries such as Myanmar, Indonesia, Mexico and U.S.A.”